Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Capital Expenditures (2018 - 2025)

BioNexus Gene Lab's Capital Expenditures history spans 8 years, with the latest figure at $977.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $977.0 for Q4 2025, down 75.71% from a year ago — trailing twelve months through Dec 2025 was $36971.0 (down 83.71% YoY), and the annual figure for FY2025 was $36971.0, down 83.71%.
  • Capital Expenditures for Q4 2025 was $977.0 at BioNexus Gene Lab, down from $5483.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $199189.0 in Q3 2024 to a low of -$32191.0 in Q2 2022.
  • The 5-year median for Capital Expenditures is $4752.5 (2024), against an average of $23534.6.
  • The sharpest move saw Capital Expenditures surged 33400.0% in 2021, then crashed 4933.48% in 2022.
  • Year by year, Capital Expenditures stood at $1279.0 in 2021, then soared by 1231.27% to $17027.0 in 2022, then crashed by 94.5% to $937.0 in 2023, then surged by 329.24% to $4022.0 in 2024, then crashed by 75.71% to $977.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $977.0, $5483.0, and $21459.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.